Angina pectoris ppt

24
Angina pectoris Sudden,severe,pressing chest pain starting substernal &radiate to left arm. Due to imbalance between myocardium oxygen requirement and oxygen supply. Risk factors : Age,sex,obesity.smoking,diabet es.

description

presentation on angina , angina pectoris and its treatment strategies

Transcript of Angina pectoris ppt

Page 1: Angina pectoris ppt

Angina pectoris

Sudden,severe,pressing chest pain starting substernal &radiate to left arm.Due to imbalance between myocardium oxygen requirement and oxygen supply.Risk factors : Age,sex,obesity.smoking,diabetes.

Page 2: Angina pectoris ppt

Classification of angina

1. Exertional angina, Stable,Atherosclerotic,Classic,

Due to obstruction of coronaries by atheroma.

2. Variant, Vasospastic angina

due to Spasm of coronaries.

3- Unstable angina.

Due to spasm and partial obstruction of coronaries.

Page 3: Angina pectoris ppt

Nitrates & Nitrites

Preparations :1- Short acting:Start within few minutes and total duration of action 15-30 minutes.A) Nitroglycerine (Glyceryl trinitrate)Used as sublingual tablets.B) Isosorbide dinitrate As sublingual spray.C) Amyl nitrite

Inhalation

Page 4: Angina pectoris ppt

2- Long acting

Nitroglycerine, Isosorbide dinitrate,Isosorbide mononitrate,Erythrityl –Tetranitrate.Action of all start withen hours and

continue for hours .

They are given : Orally,Ointment,Buccal,Transdermal patch,Parenteral.

Page 5: Angina pectoris ppt

Absorption

Well absorbed according to the route:

GIT for the long acting

short acting Sublingual

Transdermal for long acting

inhaLation

Page 6: Angina pectoris ppt

Metabolism

Through first pass hepatic metabolism .

Short acting have a low oral bioavailability (10-20%),so not given orally to avoid first pass metabolism.

Nitroglycerine metabolites( two dinitro And two mononitro forms).

The dinitro forms are active metabolites and have significant vasodilator effect.

Page 7: Angina pectoris ppt

Metabolism

Isosorbide dinitrate metabolite (5- mononitrate) is an active metabolite used clinically.

Excretion

As metabolites through kidney.

Page 8: Angina pectoris ppt

Mechanism of action

Glutathione S-transferase

Nitroglycerine ———————— No.guanylyl cyclase and NO activates increase c GMPc GMP dephosphorelate myosin light chain (Myosin-LC-po4 ) to myosin- LC Causing muscle relaxation.

Page 9: Angina pectoris ppt

Pharmacological actions

Nitrates relax all types of smooth muscles vascular or non vascular .Relax both arteries and veins but more effective on veins.They have no direct effect on cardiac or skeletal muscles.NO released stimulate guanylyl cyclase In platelets causing increase cGMP that decrease platelet aggregation.

Page 10: Angina pectoris ppt

Clinical uses

Short acting for acute attacks Long acting for prophylactic.

Treatment of all types of angina .

Page 11: Angina pectoris ppt

1- Angina of effort

A) Decrease venous return

B) Decrease ABP

Both A&B decrease myocardial oxygen requirement.

Page 12: Angina pectoris ppt

2-Variant angina

Relax smooth muscle of epicardial coronary artery and relief coronary spasm.

Page 13: Angina pectoris ppt

Unstable angina

Decrease myocardial oxygen requirement.

Relief coronary spasm.

Decrease platelet aggregation.

Page 14: Angina pectoris ppt

Adverse effects

Orthostatic hypotension

Throbbing headache

Tachycardia

Facial or cutaneous flushing

Tolerance (Tachyphylaxis)

Salt and water retention

Carcinogenicity

Methaemoglobinemia only with nitrities

Page 15: Angina pectoris ppt

Contraindication

Nitrates are contraindicated in increase intracranial pressure.

Nitrates can be used safely in increase of intraocular pressure (Glucoma).

Page 16: Angina pectoris ppt

Calcium channel blockers

1- They block calcium entry in myocardium causing ;

A) decrease myocardium contractility & myocardium oxygen requirement.

B) decrease heart rate causing decrease in myocardium oxygen requirement.

Page 17: Angina pectoris ppt

2-Block calcium entry in vascular smooth muscles (arterioles) causing a)decrease in peripheral resistance( after load)------ decrease in oxygen requirement.

• b)Relief of coronary spasm.

Page 18: Angina pectoris ppt

Clinical uses

In all types of angina but very effective in variant angina .

Used mainly in prophylactic therapy.

Page 19: Angina pectoris ppt

β-Adrenoceptor blocking drugs

They are not vasodilators They are used in treatment of angina :They decrease both heart rate & myocardial contractility that decrease in myocardial oxygen requirement at rest & in exercise so improve exercise tolerance.

Page 20: Angina pectoris ppt

Clinical uses

They are effective in the prophylactic treatment of classic & unstable angina.

They are not used in variant angina.

They are effective in treatment of silent or ambulatory angina (no pain ).

Decrease mortality of patients with recent myocardial infarction.

Page 21: Angina pectoris ppt

Potassium channel openers(Nicorandil )

Activation of potassium channels.

Nitric oxide release.

Arterio & venodilators.

Used as prophylactic therapy .

May cause : Headache,flushing,dizziness.

Page 22: Angina pectoris ppt

Drug treatment of angina

1- Acute attack :

Short acting nitrates or nitritis.

2- Prophylactic therapy ;

Long –acting nitrates.

Calcium channel blockers.

β- adrenoceptors blockers.

Potassium channel openers.

Page 23: Angina pectoris ppt

Combination therapy

Nitrates and β-adrenoceptors blockers.Calcium channel blockers and β-adrenoceptor blockers .? ?Calcium channel blockers and nitrates.Calcium channel blockers, β-adrenoceptor blockers, nitrates.

Page 24: Angina pectoris ppt

Surgical therapy

Ballon

Coronary by pass.